Vertex Pharmaceuticals Statistics
Total Valuation
VRTX has a market cap or net worth of $124.35 billion. The enterprise value is $114.87 billion.
Important Dates
The last earnings date was Monday, February 10, 2025, after market close.
| Earnings Date | Feb 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
VRTX has 256.79 million shares outstanding. The number of shares has decreased by -1.00% in one year.
| Current Share Class | 256.79M |
| Shares Outstanding | 256.79M |
| Shares Change (YoY) | -1.00% |
| Shares Change (QoQ) | -0.19% |
| Owned by Insiders (%) | 0.24% |
| Owned by Institutions (%) | 94.06% |
| Float | 255.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 26.74 |
| PS Ratio | 11.33 |
| Forward PS | 10.22 |
| PB Ratio | 7.58 |
| P/TBV Ratio | 8.58 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.37 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 10.42 |
| EV / EBITDA | 24.06 |
| EV / EBIT | 25.01 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.69, with a Debt / Equity ratio of 0.11.
| Current Ratio | 2.69 |
| Quick Ratio | 2.17 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 0.36 |
| Debt / FCF | n/a |
| Interest Coverage | 150.08 |
Financial Efficiency
Return on equity (ROE) is -3.15% and return on invested capital (ROIC) is 15.71%.
| Return on Equity (ROE) | -3.15% |
| Return on Assets (ROA) | 12.68% |
| Return on Invested Capital (ROIC) | 15.71% |
| Return on Capital Employed (ROCE) | 24.21% |
| Revenue Per Employee | $1.81M |
| Profits Per Employee | -$87,803 |
| Employee Count | 6,100 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 1.57 |
Taxes
In the past 12 months, VRTX has paid $784.10 million in taxes.
| Income Tax | 784.10M |
| Effective Tax Rate | 315.53% |
Stock Price Statistics
The stock price has increased by +15.12% in the last 52 weeks. The beta is 0.41, so VRTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | +15.12% |
| 50-Day Moving Average | 440.76 |
| 200-Day Moving Average | 464.11 |
| Relative Strength Index (RSI) | 65.58 |
| Average Volume (20 Days) | 1,546,448 |
Short Selling Information
The latest short interest is 4.56 million, so 1.78% of the outstanding shares have been sold short.
| Short Interest | 4.56M |
| Short Previous Month | 4.39M |
| Short % of Shares Out | 1.78% |
| Short % of Float | 1.78% |
| Short Ratio (days to cover) | 2.92 |
Income Statement
In the last 12 months, VRTX had revenue of $11.02 billion and -$535.60 million in losses. Loss per share was -$2.08.
| Revenue | 11.02B |
| Gross Profit | 9.49B |
| Operating Income | 4.59B |
| Pretax Income | 214.70M |
| Net Income | -535.60M |
| EBITDA | 4.77B |
| EBIT | 4.59B |
| Loss Per Share | -$2.08 |
Full Income StatementBalance Sheet
The company has $6.12 billion in cash and $1.75 billion in debt, giving a net cash position of $9.47 billion or $36.90 per share.
| Cash & Cash Equivalents | 6.12B |
| Total Debt | 1.75B |
| Net Cash | 9.47B |
| Net Cash Per Share | $36.90 |
| Equity (Book Value) | 16.41B |
| Book Value Per Share | 63.87 |
| Working Capital | 6.03B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$492.60 million and capital expenditures -$297.70 million, giving a free cash flow of -$790.30 million.
| Operating Cash Flow | -492.60M |
| Capital Expenditures | -297.70M |
| Free Cash Flow | -790.30M |
| FCF Per Share | -$3.08 |
Full Cash Flow StatementMargins
Gross margin is 86.11%, with operating and profit margins of 41.67% and -4.86%.
| Gross Margin | 86.11% |
| Operating Margin | 41.67% |
| Pretax Margin | 2.25% |
| Profit Margin | -4.86% |
| EBITDA Margin | 43.33% |
| EBIT Margin | 41.67% |
| FCF Margin | n/a |
Dividends & Yields
VRTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.00% |
| Shareholder Yield | 1.00% |
| Earnings Yield | -0.43% |
| FCF Yield | -0.64% |
Dividend DetailsAnalyst Forecast
The average price target for VRTX is $505.61, which is 4.41% higher than the current price. The consensus rating is "Buy".
| Price Target | $505.61 |
| Price Target Difference | 4.41% |
| Analyst Consensus | Buy |
| Analyst Count | 25 |
| Revenue Growth Forecast (5Y) | 9.20% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on August 24, 2000. It was a forward split with a ratio of 2:1.
| Last Split Date | Aug 24, 2000 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
VRTX has an Altman Z-Score of 13.47 and a Piotroski F-Score of 3.
| Altman Z-Score | 13.47 |
| Piotroski F-Score | 3 |